Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.47 | N/A |
PEG Ratio (TTM) | 0.06 | N/A |
P/S Ratio (TTM) | 1.60 | N/A |
P/B Ratio (TTM) | 0.56 | N/A |
P/FCF Ratio (TTM) | -0.52 | N/A |
Price to 5YR AVG Earnings Ratio | -0.50 | N/A |
Price to 5YR AVG FCF Ratio | -0.68 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -64.28% | N/A |
ROE (TTM) | -80.13% | N/A |
Net Profit Margin (TTM) | -340.96% | N/A |
ROIC 5YR AVG | -69.97% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -42.90% | -9.41% | -0.96% |
Revenue | 196.08% | 78.12% | 101.57% |
Net Income | -42.80% | -23.36% | -11.09% |
Cash Flow | -23.39% | -107.42% | -61.01% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.75 | N/A |
Quick Ratio (TTM) | 3.75 | N/A |
D/E Ratio (TTM) | 0.09 | N/A |
Interest Coverage (TTM) | -65.88 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.17 | N/A |
Shares Outstanding Growth 5YR AVG | 10.19% | N/A |